Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis

NCT05166499 is registered in ClinicalTrials.gov with The Cleveland Clinic as lead sponsor.

NCT NCT05166499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05166499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
HMB Enriched Amino Acids to Reverse Muscle Loss in Cirrhosis
Lead sponsor
The Cleveland Clinic
Phase
Not applicable
Overall status
Recruiting
Start date
November 30, 2021
Completion date
December 30, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cirrhosis, liver